Healthy Skepticism Library item: 6580

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

SmithKline Beecham claims Augmentin provides: “success that rises above resistance”
MaLAM International News 1995 Apr; 13:(4):1-2

Abstract:

SmithKline Beecham’s promotion seems to be significantly worse than that of other companies based on information from the United States, United Kingdom and France. In Sri Lanka the company promotes Augmentin as a first-line agent but has not provided any evidence to back up that position.

Keywords:
*analysis/Sri Lanka/United States/United Kingdom/France/developing countries/developed countries/quality of information/company responses/SmithKline Beecham/antibiotics/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: ANTIBIOTICS